All In Biotech

Free tool

FAERS Monitor: Nourianz

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022075 or its brand name (Nourianz, Istradefylline). Reports on generic versions are filed under their own applications.

Reports

5,984

Serious

2,641

44% of reports

Hospitalization

783

Death reported

937

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death726
  • drug ineffective634
  • hallucination617
  • dyskinesia484
  • condition aggravated464
  • dizziness423
  • product dose omission issue363
  • constipation357
  • fall352
  • tremor272
  • therapy non-responder252
  • insomnia229
  • fatigue203
  • nausea200
  • parkinson^s disease185

Reports by year received

View as table
YearReports
20144
20152
20162
20175
201825
2019133
20201,509
20211,206
20221,004
2023610
2024678
2025599
2026207

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,175 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

FDA's data service returned an error (400). The numbers below may be missing or incomplete.
ReactionReportsPRR95% CI lowerChi-squared
dyskinesiaSignal48442.438.919,305
hallucinationSignal61729.026.916,578
therapy non-responderSignal25219.817.64,467
tremorSignal2725.85.11,074
constipationSignal3575.85.21,412
condition aggravatedSignal4645.44.91,668
product dose omission issueSignal3634.33.9943
fallSignal3523.73.4708
insomniaSignal2293.02.7312
dizzinessSignal4233.02.7568
deathSignal7263.02.8982
drug ineffective6341.71.6190
fatigue2030.90.82
nausea2000.90.83
parkinson^s disease1850.00.0647,213

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.